Singulair

Allergies are hard to treat-60 percent of the springtime allergy sufferers we surveyed had limited success managing their itchy eyes, sinus pain...

Merck (MRK) raised the lower end of its full-year guidance as its topped analysts' estimates for the third quarter. The company raised the low end...

Courtesy of Pharmboy of Phil's Stock World . . Theravance (THRX) is a biopharmaceutical company that is involved in discovering, developing and...

LONDON (Reuters) - Rarely prescribed asthma pills made by drugmakers such as AstraZeneca and Merck are easier to use and just as effective as conventional inhaler treatments, according to research by British scientists.In a study in the New England Journal of Medicine ...

This post appeared yesterday on RealMoney. Click here for a free trial, and enjoy incisive commentary all day, every day. For Thomas's preview...

Posted on 04/29/11 at 12:48pm by Jonathan Chen . Merck & Co., Inc. (NYSE: MRK ) reported strong earnings today, and shares are higher, as Wall...

Singulair is a the brand name for the drug Montelukast which is used to treat asthma and allergic rhinitis . Singulair is also used to prevent breathing difficulties during exercise. Singulair comes in tablet, chewable tablets and powder form. dizziness , cough , diarrhea , nausea ...

Montelukast (trade name Singulair )is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal Merck have sought permission to market a combined tablet with loratadine (Claritin) and montelukast (Singulair), as many patients combine ...

Citigroup is out with a research report this morning, where it reiterates its Buy rating on Merck (NYSE: MRK ); it has a $45.00 price target on the...

Topic: Singulair

Allergies

Merck Lifts Guidance, Sales Driven by Diabetes Treatment

The Theravance and GlaxoSmithKline Love Affair

Asthma pills as good as inhaler: study

Astra, Merck asthma pills as good as inhaler: study

Merck Makes Good

Merck Up On Strong Earnings Today (MRK)

Montelukast

Citigroup Reiterates Buy Rating on Merck (MRK)

Video Gallery

Follow this Topic with...